206 related articles for article (PubMed ID: 9748122)
1. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
Walz PH; Björk P; Gunnarsson PO; Edman K; Hartley-Asp B
Clin Cancer Res; 1998 Sep; 4(9):2079-84. PubMed ID: 9748122
[TBL] [Abstract][Full Text] [Related]
2. Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans.
Bergenheim AT; Gunnarsson PO; Edman K; von Schoultz E; Hariz MI; Henriksson R
Br J Cancer; 1993 Feb; 67(2):358-61. PubMed ID: 8431366
[TBL] [Abstract][Full Text] [Related]
3. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
Yamanaka H; Shida K
Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
[TBL] [Abstract][Full Text] [Related]
5. Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma.
Bergenheim AT; Björk P; Bergh J; von Schoultz E; Svedberg H; Henriksson R
Cancer Res; 1994 Sep; 54(18):4974-9. PubMed ID: 8069865
[TBL] [Abstract][Full Text] [Related]
6. Expression and partial characterization of estramustine-binding protein (EMBP) in human breast cancer and malignant melanoma.
Björk P; Borg A; Fernö M; Nilsson S
Anticancer Res; 1991; 11(3):1173-82. PubMed ID: 1888147
[TBL] [Abstract][Full Text] [Related]
7. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
[TBL] [Abstract][Full Text] [Related]
8. Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest.
Eklöv S; Mahdy E; Wester K; Björk P; Malmström PU; Busch C; Nilsson S
Anticancer Res; 1996; 16(4A):1819-22. PubMed ID: 8712706
[TBL] [Abstract][Full Text] [Related]
9. Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.
Norlén BJ; Andersson SB; Björk P; Gunnarsson PO; Fritjofsson A
J Urol; 1988 Nov; 140(5):1058-62. PubMed ID: 3172360
[TBL] [Abstract][Full Text] [Related]
10. Estramustine binding protein (EMBP) in rat R3327 Dunning tumors: partial characterization and effect of hormonal withdrawal, hormonal replacement, and cytotoxic treatment on its expression.
Björk P; Isaacs JT; Hartley-Asp B
Prostate; 1991; 18(3):181-200. PubMed ID: 2020618
[TBL] [Abstract][Full Text] [Related]
11. Clinical study on estramustine binding protein (EMBP) in human prostate.
Shiina H; Igawa M; Ishibe T
Prostate; 1996 Sep; 29(3):169-76. PubMed ID: 8827085
[TBL] [Abstract][Full Text] [Related]
12. Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer.
Kelly WK; Zhu AX; Scher H; Curley T; Fallon M; Slovin S; Schwartz L; Larson S; Tong W; Hartley-Asp B; Pellizzoni C; Rocchetti M
Clin Cancer Res; 2003 Jun; 9(6):2098-107. PubMed ID: 12796374
[TBL] [Abstract][Full Text] [Related]
13. Estramustine-binding protein--a marker for effect of therapy in prostatic carcinoma?
Björk PA; Flüchter SH; Nelde HJ
Scand J Urol Nephrol Suppl; 1988; 107():59-64. PubMed ID: 3287599
[TBL] [Abstract][Full Text] [Related]
14. Distribution of estramustine in the BT4C rat glioma model.
Johansson M; Bergenheim AT; D'Argy R; Edman K; Gunnarsson PO; Widmark A; Henriksson R
Cancer Chemother Pharmacol; 1998; 41(4):317-25. PubMed ID: 9488601
[TBL] [Abstract][Full Text] [Related]
15. Dramatic decline in prostate-specific antigen by withdrawal of estramustine phosphate in hormone refractory prostate cancer.
Kobayashi M; Kuramoto H; Ota J; Fujimoto N
Int J Urol; 2006 Jul; 13(7):1019-21. PubMed ID: 16882080
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic tumor cell death induced by estramustine in patients with malignant glioma.
Vallbo C; Bergenheim AT; Bergström P; Gunnarsson PO; Henriksson R
Clin Cancer Res; 1998 Jan; 4(1):87-91. PubMed ID: 9516956
[TBL] [Abstract][Full Text] [Related]
17. Estramustine binding protein in human brain-tumor tissue.
von Schoultz E; Bergenheim T; Grankvist K; Henriksson R
J Neurosurg; 1991 Jun; 74(6):962-4. PubMed ID: 1709687
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer; plasma concentrations of estramustine phosphate and its metabolites.
Kirdani RY; Karr JP; Murphy GP; Sandberg AA
N Y State J Med; 1980 Aug; 80(9):1390-3. PubMed ID: 6938806
[No Abstract] [Full Text] [Related]
19. Estramustine-binding protein in carcinoma and benign hyperplasia of the human prostate.
Shiina H; Urakami S; Shirakawa H; Igawa M; Ishibe T; Usui T
Eur Urol; 1996; 29(1):106-10. PubMed ID: 8821700
[TBL] [Abstract][Full Text] [Related]
20. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein.
Björk P; Jönsson U; Andrén-Sandberg A
Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]